Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | ursodeoxycholic acid | 31401 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | ribostamycin | 176155 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | ribostamycin | 176155 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | ribostamycin | 176155 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | ribostamycin | 176155 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | ribostamycin | 176155 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | ribostamycin | 176155 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | ribostamycin | 176155 | drug-path |
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | ribostamycin | 176155 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | ribostamycin | 176155 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | ribostamycin | 176155 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | flunarizine | 941361 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | flunarizine | 941361 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | flunarizine | 941361 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | flunarizine | 941361 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | flunarizine | 941361 | drug-path |
| Shigellosis | 0 | map05131 | etanidazole | 3276 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | etanidazole | 3276 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | etanidazole | 3276 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | etanidazole | 3276 | drug-path |